— Know what they know.
Not Investment Advice
Also trades as: IDIA.SW (SIX) · $vol 8M · 0RQE.L (LSE) · $vol 5M

IDRSF OTC

Idorsia Ltd
1W: +1.5% 1M: -13.9% 3M: -32.8% YTD: +2.5% 1Y: +17.0% 3Y: -40.2% 5Y: -80.7%
$5.38
-0.02 (-0.37%)
 
Weekly Expected Move ±5.6%
$5 $5 $5 $6 $6
OTC · Healthcare · Biotechnology · Tech Score Sell · Power 38 · $1.4B mcap · 195M float · 0.0016% daily turnover · Short 91% of daily vol

Cash Flow Trends

Operating Cash Flow
-$153M +58.6% ▲
Capital Expenditures
$14M +23.2% ▲
5Y CAGR: +8.3%
Free Cash Flow
-$167M +57.0% ▲
Dividends Paid
$0 +0.0% ▲
Buybacks
$0 +100.0% ▲
Net Change in Cash
-$18M +53.9% ▲

Cash Flow Composition

Year-over-Year Growth

View Full Cash Flow Statement
Line ItemFY2021FY2022FY2023FY2024FY2025
— Operating Activities —
Net Income-$635M-$828M-$298M-$264M-$112M
Depreciation & Amort.$18M$20M$19M$18M$17M
Stock-Based Comp.$19M$26M$23M$12M$6M
Change in Working Capital-$841K-$65M-$76M-$35M-$46M
Other Non-Cash Items$9M$1M-$297M-$101M-$18M
Operating Cash Flow-$590M-$859M-$629M-$370M-$153M
— Investing Activities —
Capital Expenditures-$31M-$27M-$9M-$3M-$471K
Acquisitions (Net)$5M-$10M$0$0$0
Investment Purchases-$1.0B-$410M-$50M$0$0
Investment Sales$1.0B$1.2B$370M$0$18M
Other Investing-$5M$10M$322M$308M-$13M
Investing Cash Flow-$53M$744M$633M$305M$4M
— Financing Activities —
Net Debt Issuance$595M$162M$0$26M$63M
Stock Repurchased-$418K$0-$197K-$80K$0
Dividends Paid$0$0$0$0$0
Other Financing$0$0-$197K$0-$16M
Financing Cash Flow$604M$162M-$197K$26M$132M
Net Change in Cash-$39M$45M-$946K-$39M-$18M
Cash End of Period$101M$146M$145M$106M$89M
Free Cash Flow-$621M-$886M-$639M-$388M-$167M

Sign in to InsiderStreet

You'll also get our free weekly newsletter with
smart money signals, market insights, and alpha ideas.
Unsubscribe anytime.

For informational purposes only. Not investment advice. Data sourced from SEC filings. Privacy Terms